Poulou Myrto
She graduated from the Department of Health Sciences Northumbrian University, Newcastle, United Kingdom (BSc in Biomedical Sciences) in 2002. In 2003 she obtained the MSc “Human Molecular Genetics” from the Imperial College of Science, Technology and Medicine, London, United Kingdom and in 2005 the diploma "European University Diploma in Molecular Cytogenetics” of the European University from department of the School of Medicine of Montpellier-Nîmes, France. From 2005 to 2022 she worked at the Laboratory of Medical Genetics of the National and Kapodistrian University of Athens where she completed her PhD in 2013. Main duties included diagnosis of Cystic Fibrosis, development on novel diagnostic methods and counselling of families. Her research interests include diagnosis of monogenic diseases (cystic fibrosis, Wilson's disease, non-syndromic deafness etc.) with molecular techniques as well as the investigation of the genetic background of multifactorial diseases (melanoma, sarcoidosis, osteoarthritis etc.). She has published 21 papers in reputable scientific journals and presented numerous papers in Greek and international conferences. She is a member of the European Society of Human Genetics (ESHG), of the European Society for Cystic Fibrosis (ESCF) and member of the European reference network for Wilson's disease (EuroWilson). She was elected member of the Board of Directors of the Medical Association Geneticists of Greece (SIGE) during a six-year period 2014-2020. From January 2023 she is head of Molecular Genetics at the Department of Genetics, Institute of Child Health, “Aghia Sofia” Children's Hospital. The Institute of Child Health is responsible the national newborn screening program for cystic fibrosis in Greece.